These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9989341

  • 1. Clinical pharmacokinetics of cisatracurium besilate.
    Kisor DF, Schmith VD.
    Clin Pharmacokinet; 1999 Jan; 36(1):27-40. PubMed ID: 9989341
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Importance of the organ-independent elimination of cisatracurium.
    Kisor DF, Schmith VD, Wargin WA, Lien CA, Ornstein E, Cook DR.
    Anesth Analg; 1996 Nov; 83(5):1065-71. PubMed ID: 8895287
    [Abstract] [Full Text] [Related]

  • 5. Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
    Atherton DP, Hunter JM.
    Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation.
    De Wolf AM, Freeman JA, Scott VL, Tullock W, Smith DA, Kisor DF, Kerls S, Cook DR.
    Br J Anaesth; 1996 May; 76(5):624-8. PubMed ID: 8688259
    [Abstract] [Full Text] [Related]

  • 7. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients.
    Ornstein E, Lien CA, Matteo RS, Ostapkovich ND, Diaz J, Wolf KB.
    Anesthesiology; 1996 Mar; 84(3):520-5. PubMed ID: 8659778
    [Abstract] [Full Text] [Related]

  • 8. Selecting neuromuscular-blocking drugs for elderly patients.
    Cope TM, Hunter JM.
    Drugs Aging; 2003 Mar; 20(2):125-40. PubMed ID: 12534313
    [Abstract] [Full Text] [Related]

  • 9. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium].
    Savarese JJ, Lien CA, Belmont MR, Wastila WB.
    Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966
    [Abstract] [Full Text] [Related]

  • 10. [Cisatracurium in patients with compromised kidney function. Pharmacodynamic and intubation conditions under isoflurane-nitrous oxide anesthesia].
    Soukup J, Czeslick E, Bunk S, Clausen T, Menzel M, Radke J.
    Anaesthesist; 1998 Aug; 47(8):669-76. PubMed ID: 9770090
    [Abstract] [Full Text] [Related]

  • 11. The in vitro degradation of cisatracurium, the R, cis-R'-isomer of atracurium, in human and rat plasma.
    Welch RM, Brown A, Ravitch J, Dahl R.
    Clin Pharmacol Ther; 1995 Aug; 58(2):132-42. PubMed ID: 7648763
    [Abstract] [Full Text] [Related]

  • 12. [The clinical pharmacology of cisatracurium].
    Mellinghoff H, Diefenbach C.
    Anaesthesist; 1997 Jun; 46(6):481-5. PubMed ID: 9297378
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
    Lien CA, Schmith VD, Belmont MR, Abalos A, Kisor DF, Savarese JJ.
    Anesthesiology; 1996 Feb; 84(2):300-8. PubMed ID: 8602660
    [Abstract] [Full Text] [Related]

  • 14. Studies on the pharmacokinetics of cisatracurium in anesthetized dogs: in vitro-in vivo correlations.
    Chen C, Yamaguchi N, Varin F.
    J Vet Pharmacol Ther; 2009 Dec; 32(6):571-6. PubMed ID: 20444012
    [Abstract] [Full Text] [Related]

  • 15. [Cisatracurium].
    Ortiz JR, Percaz JA, Carrascosa F.
    Rev Esp Anestesiol Reanim; 1998 Dec; 45(6):242-7. PubMed ID: 9719722
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients.
    Smith CE, van Miert MM, Parker CJ, Hunter JM.
    Anaesthesia; 1997 Sep; 52(9):833-41. PubMed ID: 9349062
    [Abstract] [Full Text] [Related]

  • 17. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR, Kern S, Ficke DJ, Ebert TJ.
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.
    Kirov K, Motamed C, Decailliot F, Behforouz N, Duvaldestin P.
    Acta Anaesthesiol Scand; 2004 May; 48(5):577-81. PubMed ID: 15101851
    [Abstract] [Full Text] [Related]

  • 19. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats.
    Wastila WB, Maehr RB, Turner GL, Hill DA, Savarese JJ.
    Anesthesiology; 1996 Jul; 85(1):169-77. PubMed ID: 8694363
    [Abstract] [Full Text] [Related]

  • 20. Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination.
    Fisher DM, Canfell PC, Fahey MR, Rosen JI, Rupp SM, Sheiner LB, Miller RD.
    Anesthesiology; 1986 Jul; 65(1):6-12. PubMed ID: 3755306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.